论文信息 - Early fecal calprotectin levels at week 8 may guide therapeutic decisions on Ustekinumab therapy in patients with Crohn's disease. - 字舞流文

Early fecal calprotectin levels at week 8 may guide therapeutic decisions on Ustekinumab therapy in patients with Crohn's disease.

C. J. van der Woude | M. Doukas | A. D. de Vries | L. Oudijk | R. Pauwels | Renske W M Pauwels | S Ten Bokkel Huinink | Christien J van der Woude | M Doukas | L Oudijk | Annemarie C de Vries | S. Ten Bokkel Huinink